Bamco Inc Vericel Corp Transaction History

Bamco Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $452,848 - $676,699	-12,865 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$46.35 - $59.75 $341,831 - $440,656	-7,375 Reduced 36.44%	12,865 $628,000
Q2 2021 Aug 13, 2021	BUY	$47.2 - $67.81 $767,660 - $1.1 Million	16,264 Added 409.05%	20,240 $1.06 Million
Q1 2021 May 19, 2021	BUY	$30.93 - $59.48 $122,977 - $236,492	3,976 New	3,976 $221,000

267

48.4M

91.1K

39.8K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.95B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.